139 results
6-K
GLPG
Galapagos NV
1 May 24
Current report (foreign)
5:10pm
the coordinated text of the Company’s articles of association in the electronic database provided for that purpose under the applicable laws.
Agenda
6-K
EX-99.4
GLPG
Galapagos NV
29 Mar 24
Galapagos publishes 2023 annual report and announces Annual and Extraordinary Shareholders’ Meetings
5:03pm
, for the purpose of considering the agenda set forth below and, for this purpose, to participate in the deliberation, to vote or abstain, to sign all … of the Company’s articles of association in the electronic database provided for that purpose under the applicable laws. 7. Machtiging aan de Raad van
6-K
EX-99.7
GLPG
Galapagos NV
29 Mar 24
Galapagos publishes 2023 annual report and announces Annual and Extraordinary Shareholders’ Meetings
5:03pm
legally possible be used with priority for the purpose of the issuance of shares to Gilead Therapeutics, without prejudice to the right of the Company … of such subscription rights) have not yet been exercised and have not yet expired. For the purpose of the full-dilution scenario calculations further
6-K
EX-99.8
GLPG
Galapagos NV
29 Mar 24
Galapagos publishes 2023 annual report and announces Annual and Extraordinary Shareholders’ Meetings
5:03pm
in Belgium.
For the purpose of this mission, we must determine whether we have established facts that
cause us to believe that the financial and accounting … and may not be used for any other purpose.
Zaventem, 28 March 2024
BDO Bedrijfsrevisoren BV
Statutory Auditor
Represented by Ellen Lombaerts
6-K
EX-99.6
GLPG
Galapagos NV
29 Mar 24
Galapagos publishes 2023 annual report and announces Annual and Extraordinary Shareholders’ Meetings
5:03pm
, but not for the purpose of expressing an opinion on the effectiveness of the Company’s internal control;
GALAPAGOS NV:
Statutory auditor’s report
6-K
EX-99.5
l44vk5vx aq
29 Mar 24
Galapagos publishes 2023 annual report and announces Annual and Extraordinary Shareholders’ Meetings
5:03pm
6-K
EX-99.14
qojr5n5c07q8
29 Mar 24
Galapagos publishes 2023 annual report and announces Annual and Extraordinary Shareholders’ Meetings
5:03pm
6-K
EX-99.3
ohwcnrzji4dx2
29 Mar 24
Galapagos publishes 2023 annual report and announces Annual and Extraordinary Shareholders’ Meetings
5:03pm
6-K
EX-99.9
hi8kes
29 Mar 24
Galapagos publishes 2023 annual report and announces Annual and Extraordinary Shareholders’ Meetings
5:03pm
6-K
EX-99.2
bugl5z i5mbngg3d
29 Mar 24
Galapagos publishes 2023 annual report and announces Annual and Extraordinary Shareholders’ Meetings
5:03pm
6-K
EX-99.15
zw6b roibw439t3g9
29 Mar 24
Galapagos publishes 2023 annual report and announces Annual and Extraordinary Shareholders’ Meetings
5:03pm
6-K
EX-99.1
6rvxb9aq5562 18vvz
4 Jan 24
Galapagos establishes strategic collaboration with BridGene Biosciences to expand small molecule drug discovery in oncology
4:07pm